Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-15

FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Original Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved the original application for levocetirizine dihydrochloride (generic) from Chartwell RX, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levocetirizine dihydrochloride (LEVOCETIRIZINE DIHYDROCHLORIDE)

Snippet

ORIG AP for LEVOCETIRIZINE DIHYDROCHLORIDE (LEVOCETIRIZINE DIHYDROCHLORIDE)